Error: Could not add to watchlist. X
+ Watchlist

Intra-Cellular Therapies Inc

ITCI:US
NASDAQ GS
19.25
USD
0.70
3.51%
As of 8:10 PM EDT 9/21/2017
Open
20.04
Day Range
19.21 - 20.08
Volume
519,291
Previous Close
19.95
52Wk Range
7.85 - 42.83
1 Yr Return
-52.90%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
20.04
Day Range
19.21 - 20.08
Volume
519,291
Previous Close
19.95
52Wk Range
7.85 - 42.83
1 Yr Return
-52.90%
YTD Return
27.57%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.37
Market Cap (m USD)
835.918
Shares Outstanding (m)
43.424
Price/Sales (TTM)
2,672.86
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.56%
% Price Change
-0.53%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Intra-Cellular Therapies Inc. researches and develops biopharmaceutical drugs. The Company engages in the research and development of small molecule drugs to treat neuropsychiatric and neurological diseases and other disorders of the central nervous system. Intra-Cellular Therapies offers its products to the medical industry.
Address
430 East 29th Street
Suite 900
New York, NY 10016
United States
Phone
1-646-440-9333
Show More